Oral therapeutic agents in fungal nail disease
- 30 September 1994
- journal article
- review article
- Published by Elsevier in Journal of the American Academy of Dermatology
- Vol. 31 (3), S78-S81
- https://doi.org/10.1016/s0190-9622(08)81274-1
Abstract
No abstract availableKeywords
This publication has 23 references indexed in Scilit:
- Posttreatment itraconazole levels in the nailJournal of the American Academy of Dermatology, 1992
- Prevalence of dermatophyte onychomycosis in the United Kingdom: Results of an omnibus surveyBritish Journal of Dermatology, 1992
- Terbinafine: Mode of action and properties of the squalene epoxidase inhibitionBritish Journal of Dermatology, 1992
- Selective action of allylamines and its therapeutic implicationsJournal of Dermatological Treatment, 1992
- Itraconazole penetrates the nail via the nail matrix and the nail bed-an investigation in onychomycosisClinical and Experimental Dermatology, 1991
- Determination of terbinafine in nail samples during systemic treatment for onychomycosesBritish Journal of Dermatology, 1990
- In vitro activity of terbinafineClinical and Experimental Dermatology, 1989
- A method for the determination of drug effectiveness in onychomycosis: Trials with ketoconazole and griseofulvin ultramicrosizeJournal of the American Academy of Dermatology, 1983
- Mechanism of Action of Antifungal Drugs, with Special Reference to the Imidazole DerivativesClinical Infectious Diseases, 1980
- Mycological and Clinical Evaluation of Griseofulvin for Chronic OnychomycosisBMJ, 1967